Pfizer, BioNTech in EU Vaccine Deal That’s Their Biggest Yet (1)

Pfizer Inc. and BioNTech SE reached a preliminary agreement to supply 200 million doses of their experimental Covid-19 vaccine to the European Union -- the biggest initial order yet for the U.S.-German partners.

The European Commission has concluded exploratory talks and will now begin contract negotiations, according to a statement Wednesday. The deal would include an option for another 100 million doses.

The EU didn’t disclose financial terms. Pfizer and BioNTech previously agreedto supply 120 million doses to Japan. The U.S. in July reached a deal to pay $2 billion for an initial 100 million doses, with an option ...